Jury To Weigh Lost Profits In Neurontin Patent Fight
A New Jersey federal judge ruled Monday that a jury should decide whether Pfizer Inc. is entitled to lost profits in its long-running patent infringement case against several generics makers over...To view the full article, register now.
Already a subscriber? Click here to view full article